Sign in

CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831971007
Phone
650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
  1. DEF 14A Proxy Proxy Statement
  2. DEF 14A Proxy Proxy Statement
  3. DEF 14A Proxy Proxy Statement
  4. PRE 14A Proxy Proxy Statement (Preliminary)
  5. DEF 14A Proxy Proxy Statement
  6. DEF 14A Proxy Proxy Statement
  7. PRE 14A Proxy Proxy Statement (Preliminary)
  8. DEF 14A Proxy Proxy Statement
  9. DEF 14A Proxy Proxy Statement

Page 1 of 1 · 9 filings